• 1
    Patterson MB, Mack JL & Mackell JA et al. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: The CERAD behavior rating scale for dementia. Alzheimer Dis. Assoc. Disord. 1997; 11 (Suppl. 2): S40S44.
  • 2
    Teri L. Behavior and caregiver burden: Behavioral problems in patients with Alzheimer disease and its association with caregiver distress. Alzheimer Dis. Assoc. Disord. 1997; 11 (Suppl. 4): S35S38.
  • 3
    Cooper JK, Mungas D & Weiler PG. Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J. Am. Geriatr. Soc. 1990; 38: 867870.
  • 4
    Teri L, Larson EB & Reifler BV. Behavioral disturbance in dementia of the Alzheimer's type. J. Am. Geriatr. Soc. 1988; 36: 16.
  • 5
    Swearer JM, Drachman DA, O'donnell BF & Mitchell AL. Troublesome and disruptive behaviors in dementia. J. Am. Geriatr. Soc. 1988; 36: 784790.
  • 6
    Ramachandran G, Marder Tang M & Schofield PW et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47: 256259.
  • 7
    Murphy GmJr, Taylor J, Tinkelberg JR & Yesavage JA. The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance in Alzheimer's disease. Am. J. Geriatr. Psychiatry 1997; 5: 8889.
  • 8
    Lyketsos CG, Baker L & Warren W et al. Depression, delusion, and hallucinations in Alzheimer's disease: No relationship to apolipoprotein E genotype. J. Neuropsychiatry Clin. Neurosci. 1997; 9: 6467.
  • 9
    Cacabelos R, Rodriguez B, Carrera C, Beyer K, Lao JI & Sellers MA. Behavioral changes associated with different apolipoprotein E genotypes in dementia. Alzheimer Dis. Assoc. Disord. 1997; 11 (Suppl 4): 2734.
  • 10
    Lopez OL, Kamboh MI, Becker JT, Kaufer DI & Dekosky ST. The apolipoprotein E ɛ 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49: 794797.
  • 11
    Levy ML, Cummings JL, Fairbanks LA, Sultzer DL & Small GW. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol. Psychiatry 1999; 45: 422425.DOI: 10.1016/s0006-3223(98)00041-9
  • 12
    Wagner AW, Teri L & Orr-rainey N. Behavior problems among dementia residents in special care unit: Changes over time. J. Am. Geriatr. Soc. 1995; 43: 784787.
  • 13
    Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M & Carta A. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am. J. Psychiatry 1996; 153: 14381443.
  • 14
    Devanand DP, Jacobs DM & Tang MX et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch. Gen. Psychiatry 1997; 54: 257263.
  • 15
    Marin DB, Green CR & Schmeidler J et al. Noncognitive disturbances in Alzheimer's disease: Frequency, longitudinal course, and relationship to cognitive symptoms. J. Am. Geriatr. Soc. 1997; 45: 13311338.
  • 16
    Cohen-Mansfield J & Werner P. Longitudinal changes in behavioral problems in old age: A study in an adult day care population. J. Gerontol. 1998; 53: M65–M71.
  • 17
    Hope T, Keene J, Fairburn CG, Jacoby R & McShane R. Natural history of behavioral changes and psychiatric symptoms in Alzheimer's disease. Br. J. Psychiatry 1999; 174: 3944.
  • 18
    Asada T, Kinoshita T, Motonaga T & Kakuma T. A prospective 5-year follow-up study on the behavioral disturbances of community-dwelling elderly people with Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 1999; 13: 202208.
  • 19
    Katoh S, Simogaki H & Onodera A et al. Development of the revised version of Hasegawa's dementia scale. Jpn. J. Geriatr. Psychiatry 1991; 2: 13391347 (in Japanese).
  • 20
    Hughes CP, Berg L, Danziger WL, Coben LA & Martin RL. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982; 140: 566572.
  • 21
    McKhann G, Drachman D, Folstein M, Katzman R, Price D & Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939944.
  • 22
    Asada T, Yoshioka M & Morikawa S et al. Development of a Troublesome Behavior Scale (TBS) for the elderly patients with dementia. Jpn. J. Public Health 1994; 41: 518527 (in Japanese).
  • 23
    Goldberg DP. The detection of psychiatric illness by questionnaire. A Technique for the Identification and Assessment of Non-Psychotic Psychiatric Illness. Oxford University Press, London, 1972.
  • 24
    Corder EH, Saunder AM & Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993; 26: 921923.
  • 25
    Reisberg B, Borensteib J, Salob SP, Ferris SH, Franssen E & Georgotas A. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J. Clin. Psychiatry 1987; 5 (Suppl): 915.
  • 26
    Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA & Gornbein J. The neuropsychiatric inventory. Neurology 1994; 44: 23082314.
  • 27
    Tariot PN, Mack JL & Patterson MB et al. The behavior rating scale for Alzheimer's disease of the Consortium to Establish a Registry for Alzheimer's Disease. Am. J. Psychiatry 1995; 152: 13491357.